WebFind the latest news headlines from Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com. WebDec 4, 2007 · Event Date: 12/31/2024: Delfin Midstream, LLC. became the majority owner (70.9%) of TGLO (theglobe.com) with 312,825,952 shares. Below are the corresponding filings and a subsequent article, alluding to the possiblity of a reverse merger based on the trend of other LNG companies performing reverse mergers (e.g., TELL).
CTSO Stock Price Forecast. Should You Buy CTSO? - StockInvest.us
WebApr 11, 2024 · Franklin Covey. $276.11 million. 1.94. $18.43 million. $1.34. 28.79. Franklin Covey has higher revenue and earnings than Veritec. Veritec is trading at a lower price-to-earnings ratio than ... WebApr 9, 2024 · Their CTSO share price forecasts range from $5.50 to $6.00. On average, they anticipate the company's share price to reach $5.75 in the next twelve months. This … das hoffmannsthal graz
CytoSorbents Reports Fourth Quarter and Full Year 2024 Results
WebApr 11, 2024 · Discover historical prices for CTSO stock on Yahoo Finance. View daily, weekly or monthly format back to when Cytosorbents Corporation stock was issued. WebJul 21, 2024 · Shares of CytoSorbents ( CTSO -0.28%) were getting clobbered on Tuesday, with the stock sinking 15.9% as of 3:14 p.m. EDT. The big decline came after the maker of blood purification technologies ... WebNov 3, 2024 · PRNewswire/ -- CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q2 2024 financial results after the market close on … dash of colour rush